Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Dec;32(12):1747–1753. doi: 10.1128/aac.32.12.1747

Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

G V Doern 1, R N Jones 1
PMCID: PMC176011  PMID: 3149883

Full text

PDF
1747

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez S., Jones M., Holtsclaw-Berk S., Guarderas J., Berk S. L. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashford W. A., Potts D. W., Adams H. J., English J. C., Johnson S. R., Biddle J. W., Thornsberry C., Jaffe H. W. Spectinomycin-resistant penicillinase-producing Neisseria gonorrhoeae. Lancet. 1981 Nov 7;2(8254):1035–1037. doi: 10.1016/s0140-6736(81)91227-7. [DOI] [PubMed] [Google Scholar]
  3. Azemun P., Stull T., Roberts M., Smith A. L. Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1981 Aug;20(2):168–170. doi: 10.1128/aac.20.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bell S. M., Plowman D. Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet. 1980 Feb 9;1(8163):279–280. doi: 10.1016/s0140-6736(80)90778-3. [DOI] [PubMed] [Google Scholar]
  5. Bergeron M. G., Simard P., Provencher P. Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics. J Clin Microbiol. 1987 Apr;25(4):650–655. doi: 10.1128/jcm.25.4.650-655.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Biddle J. W., Swenson J. M., Thornsberry C. Disc agar diffusion antimicrobial susceptibility tests with beta-lactamase producing Neisseria gonorrhoeae. J Antibiot (Tokyo) 1978 Apr;31(4):352–358. doi: 10.7164/antibiotics.31.352. [DOI] [PubMed] [Google Scholar]
  7. Bulger R. R., Washington J. A., 2nd Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species. Antimicrob Agents Chemother. 1980 Mar;17(3):393–396. doi: 10.1128/aac.17.3.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burns J. L., Mendelman P. M., Levy J., Stull T. L., Smith A. L. A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1985 Jan;27(1):46–54. doi: 10.1128/aac.27.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Catlin B. W. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance. Antimicrob Agents Chemother. 1975 Mar;7(3):265–270. doi: 10.1128/aac.7.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davies B. I., Maesen F. P. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):28–33. doi: 10.2165/00003495-198600313-00008. [DOI] [PubMed] [Google Scholar]
  11. Doern G. V. Branhamella catarrhalis--an emerging human pathogen. Diagn Microbiol Infect Dis. 1986 Mar;4(3):191–201. doi: 10.1016/0732-8893(86)90098-2. [DOI] [PubMed] [Google Scholar]
  12. Doern G. V., Chapin K. C. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole. Diagn Microbiol Infect Dis. 1986 Jan;4(1):37–41. doi: 10.1016/0732-8893(86)90054-4. [DOI] [PubMed] [Google Scholar]
  13. Doern G. V., Daum G. S., Tubert T. A. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Sep;25(9):1675–1678. doi: 10.1128/jcm.25.9.1675-1678.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Doern G. V., Daum G. S., Tubert T. A. In vitro chloramphenicol susceptibility testing of Haemophilus influenzae: disk diffusion procedures and assays for chloramphenicol acetyltransferase. J Clin Microbiol. 1987 Aug;25(8):1453–1455. doi: 10.1128/jcm.25.8.1453-1455.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Doern G. V., Jorgensen J. H., Thornsberry C., Preston D. A., Tubert T., Redding J. S., Maher L. A. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother. 1988 Feb;32(2):180–185. doi: 10.1128/aac.32.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doern G. V., Miller M. J., Winn R. E. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch Intern Med. 1981 Nov;141(12):1690–1692. [PubMed] [Google Scholar]
  17. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Doern G. V., Tubert T. A. Detection of beta-lactamase activity among clinical isolates of Branhamella catarrhalis with six different beta-lactamase assays. J Clin Microbiol. 1987 Aug;25(8):1380–1383. doi: 10.1128/jcm.25.8.1380-1383.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Doern G. V., Tubert T. A. In vitro activities of 39 antimicrobial agents for Branhamella catarrhalis and comparison of results with different quantitative susceptibility test methods. Antimicrob Agents Chemother. 1988 Feb;32(2):259–261. doi: 10.1128/aac.32.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Doern G. V., Tubert T. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob Agents Chemother. 1987 Oct;31(10):1519–1523. doi: 10.1128/aac.31.10.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Doern G. V., Tubert T. Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis. J Clin Microbiol. 1987 Aug;25(8):1576–1578. doi: 10.1128/jcm.25.8.1576-1578.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Elwell L. P., De Graaff J., Seibert D., Falkow S. Plasmid-linked ampicillin resistance in haempohilus influenza type b. Infect Immun. 1975 Aug;12(2):404–410. doi: 10.1128/iai.12.2.404-410.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Farmer T., Reading C. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors. Drugs. 1986;31 (Suppl 3):70–78. doi: 10.2165/00003495-198600313-00015. [DOI] [PubMed] [Google Scholar]
  24. Hafiz S., McEntegart M. G. Prolonged survival of Neisseria gonorrhoeae in a new liquid medium. Br J Vener Dis. 1976 Dec;52(6):381–383. doi: 10.1136/sti.52.6.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jaffe H. W., Biddle J. W., Thornsberry C., Johnson R. E., Kaufman R. E., Reynolds G. H., Wiesner P. J. National gonorrhea therapy monitoring study: in vitro antibiotic susceptibility and its correlation with treatment results. N Engl J Med. 1976 Jan 1;294(1):5–9. doi: 10.1056/NEJM197601012940102. [DOI] [PubMed] [Google Scholar]
  26. Johnson M. A., Drew W. L., Roberts M. Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol. 1981 Jun;13(6):1066–1069. doi: 10.1128/jcm.13.6.1066-1069.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jones R. N., Sommers H. M. Identification and antimicrobial susceptibility testing of Branhamella catarrhalis in United States laboratories, 1983-1985. Drugs. 1986;31 (Suppl 3):34–37. doi: 10.2165/00003495-198600313-00009. [DOI] [PubMed] [Google Scholar]
  28. Jorgensen J. H., Crawford S. A., Alexander G. A. Pyridinium-2-azo-p-dimethylaniline chromophore, a new chromogenic cephalosporin for rapid beta-lactamase testing. Antimicrob Agents Chemother. 1982 Jul;22(1):162–164. doi: 10.1128/aac.22.1.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jorgensen J. H., Maher L. A., Redding J. S. Disk diffusion interpretive criteria for extended-spectrum cephalosporins with Haemophilus influenzae. J Clin Microbiol. 1988 Sep;26(9):1887–1889. doi: 10.1128/jcm.26.9.1887-1889.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jorgensen J. H., Redding J. S., Maher L. A., Howell A. W. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Nov;25(11):2105–2113. doi: 10.1128/jcm.25.11.2105-2113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Labia R., Barthelemy M., Le Bouguennec C. B., Buu Hoi-Dang Van A. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species. Drugs. 1986;31 (Suppl 3):40–47. doi: 10.2165/00003495-198600313-00011. [DOI] [PubMed] [Google Scholar]
  32. Louie M. H., Gabay E. L., Mathisen G. E., Finegold S. M. Branhamella catarrhalis pneumonia. West J Med. 1983 Jan;138(1):47–49. [PMC free article] [PubMed] [Google Scholar]
  33. Luman I., Wilson R. W., Wallace R. J., Jr, Nash D. R. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production. Antimicrob Agents Chemother. 1986 Nov;30(5):774–776. doi: 10.1128/aac.30.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Maier T. W., Beilstein H. R., Zubrzycki L. Antibiotic disk susceptibility tests with Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1974 Mar;5(3):210–216. doi: 10.1128/aac.5.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Markowitz S. M. Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother. 1980 Jan;17(1):80–83. doi: 10.1128/aac.17.1.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Marks M. I., Weinmaster G. Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol. Antimicrob Agents Chemother. 1975 Dec;8(6):657–663. doi: 10.1128/aac.8.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Martin J. E., Jr, Lester A., Price E. V., Schmale J. D. Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969. J Infect Dis. 1970 Nov;122(5):459–461. doi: 10.1093/infdis/122.5.459. [DOI] [PubMed] [Google Scholar]
  38. Medeiros A. A., Levesque R., Jacoby G. A. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother. 1986 Feb;29(2):212–215. doi: 10.1128/aac.29.2.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Mendelman P. M., Chaffin D. O., Clausen C., Stull T. L., Needham C., Williams J. D., Smith A. L. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother. 1986 Aug;30(2):274–280. doi: 10.1128/aac.30.2.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mendelman P. M., Chaffin D. O., Stull T. L., Rubens C. E., Mack K. D., Smith A. L. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984 Aug;26(2):235–244. doi: 10.1128/aac.26.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Morse S. A., Johnson S. R., Biddle J. W., Roberts M. C. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother. 1986 Nov;30(5):664–670. doi: 10.1128/aac.30.5.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Needham C. A. Haemophilus influenzae: antibiotic susceptibility. Clin Microbiol Rev. 1988 Apr;1(2):218–227. doi: 10.1128/cmr.1.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Oberhofer T. R., Towle D. W. Evaluation of the rapid penicillinase paper strip test for detection of beta-lactamase. J Clin Microbiol. 1982 Feb;15(2):196–199. doi: 10.1128/jcm.15.2.196-199.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Offit P. A., Campos J. M., Plotkin S. A. Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. Pediatrics. 1982 Feb;69(2):230–232. [PubMed] [Google Scholar]
  46. Parr T. R., Jr, Bryan L. E. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother. 1984 Jun;25(6):747–753. doi: 10.1128/aac.25.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. REYN A., BENTZON M. W., ERICSSON H. Comparative investigations of the sensitivity of N. gonorrhoeae to penicillin. Acta Pathol Microbiol Scand. 1963;57:235–255. doi: 10.1111/j.1699-0463.1963.tb03447.x. [DOI] [PubMed] [Google Scholar]
  48. Rice R. J., Biddle J. W., JeanLouis Y. A., DeWitt W. E., Blount J. H., Morse S. A. Chromosomally mediated resistance in Neisseria gonorrhoeae in the United States: results of surveillance and reporting, 1983-1984. J Infect Dis. 1986 Feb;153(2):340–345. doi: 10.1093/infdis/153.2.340. [DOI] [PubMed] [Google Scholar]
  49. Rubin L. G., Medeiros A. A., Yolken R. H., Moxon E. R. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet. 1981 Nov 7;2(8254):1008–1010. doi: 10.1016/s0140-6736(81)91214-9. [DOI] [PubMed] [Google Scholar]
  50. Shapiro M. A., Heifetz C. L., Sesnie J. C. Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae. J Clin Microbiol. 1984 Oct;20(4):828–830. doi: 10.1128/jcm.20.4.828-830.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Shurin P. A., Marchant C. D., Kim C. H., Van Hare G. F., Johnson C. E., Tutihasi M. A., Knapp L. J. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis. 1983 Jan-Feb;2(1):34–38. doi: 10.1097/00006454-198301000-00009. [DOI] [PubMed] [Google Scholar]
  52. Skinner A., Wise R. A comparison of three rapid methods for the detection of beta-lactamase activity in Haemophilus influenzae. J Clin Pathol. 1977 Nov;30(11):1030–1032. doi: 10.1136/jcp.30.11.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stobberingh E. E., van Eck H. J., Houben A. W., van Boven C. P. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis. Drugs. 1986;31 (Suppl 3):23–27. doi: 10.2165/00003495-198600313-00007. [DOI] [PubMed] [Google Scholar]
  54. Sweeney K. G., Verghese A., Needham C. A. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother. 1985 Apr;27(4):499–502. doi: 10.1128/aac.27.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Syriopoulou V. P., Scheifele D. W., Sack C. M., Smith A. L. Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother. 1979 Oct;16(4):510–513. doi: 10.1128/aac.16.4.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Thornsberry C., Kirven L. A. Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production. Antimicrob Agents Chemother. 1974 Nov;6(5):653–654. doi: 10.1128/aac.6.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Washington J. A., 2nd, Snyder R. J., Kohner P. C. Spurious ampicillin resistance by testing Haemophilus influenzae with agar containing supplement C. Antimicrob Agents Chemother. 1976 Jan;9(1):199–200. doi: 10.1128/aac.9.1.199. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES